ADALIMUMAB
adalimumab 40 mg/0.8 mL injection, 2 x 0.8 mL pen devices
ADALIMUMAB (15140W)
15140W
Manner of administration:Injection
Restriction
Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Transitioning from non-PBS to PBS-subsidised treatment - Grandfather arrangements
